公开(公告)号：HK1122292A1

公开(公告)日：2009-05-15

申请号：HK09101289

申请日：2009-02-11

Applicant: ABBOTT LAB DEPT

Inventor： ROCKWAY TODD W ,  BETEBENNER DAVID A ,  KRUEGER ALLAN C ,  IWASAKI NOBUHIKO ,  COOPER CURT S ,  ANDERSON DAVID D ,  KEMPF DALE J ,  MADIGAN DAROLD L ,  MOTTER CHRISTOPHER E ,  SHANLEY JASON P ,  TUFANO MICHAEL D ,  WAGNER ROLF ,  ZHANG RONG ,  MOLLA AKHTERUZZAMAN ,  MO HONGMEI ,  PILOT-MATIAS TAMI ,  MASSE SHERIE VL ,  CARRICK ROBERT J ,  HE WEPING ,  LU LIANGJUN

IPC: C07D20060101

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (HCV) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.